Autoimmune Diseases  >>  DegludecPlus (insulin degludec/insulin aspart)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk
NCT02230618: Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India

Completed
N/A
1029
RoW
insulin degludec/insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
06/17
06/17

Download Options